Clinical trial
Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure…
NCT00221013 · The George Institute, Other · Completed
Key facts
| NCT number | NCT00221013 |
|---|---|
| Title | Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF). |
| Official title | Multicentre, Unblinded, Open Label, Randomised, Controlled Trial to Assess the Effect of Augmented Vs. Normal Continuous Renal Replacement Therapy (CRRT) on 90-Day All-Cause Mortality of Intensive Care Unit Patients With Severe Acute Renal Failure (ARF). |
| Lead sponsor | The George Institute, Other |
| Collaborators | ANZICS Clinical Trials Group |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Renal Failure |
| Intervention type | Procedure |
| Interventions | "augmented" CRRT regimen |
| Enrollment | 1,508 |
| Start date | Nov 1, 2005 |
| Primary completion | Oct 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 27, 2009 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: